BioCentury | Mar 4, 2013
Financial News

NanoViricides financial update

...to Seaside 88 for $2 million, including accrued dividends of $6,002.45 and a 10% redemption premium. Seaside 88...
BioCentury | Jan 7, 2013
Financial News

NanoViricides completes private placement of convertible preferred stock

...million Shares: 2,500 Price: $1,000 Placement agent: Midtown Partners Shares outstanding prior: 159.4 million Investor: Seaside 88...
BioCentury | Feb 13, 2012
Financial News

NanoViricides completes private placement of convertible preferred stock

...convertible preferred stock Raised: $2.5 million Shares: 250,000 Price: $10 Placement agent: Midtown Partners Investor: Seaside 88...
BioCentury | Nov 7, 2011
Financial News

NanoViricides completes private placement of convertible preferred stock

...million Shares: 250,000 Price: $10 Placement agent: Midtown Partners Shares outstanding prior: 145.8 million Investor: Seaside 88...
BioCentury | Aug 1, 2011
Financial News

NanoViricides completes private placement of convertible preferred stock

...million Shares: 250,000 Price: $10 Placement agent: Midtown Partners Shares outstanding prior: 142.1 million Investor: Seaside 88...
BioCentury | Jul 18, 2011
Financial News

Cytori completes private placement

...placement Raised: $6 million Shares: 1.3 million Price: $4.52 Shares after offering: 53.8 million Investor: Seaside 88...
BioCentury | Apr 25, 2011
Financial News

NanoViricides completes private placement of convertible preferred stock

...convertible preferred stock Raised: $2.5 million Shares: 250,000 Price: $10 Placement agent: Midtown Partners Investor: Seaside 88...
BioCentury | Feb 14, 2011
Finance

Hard to Mann up

...has an undisclosed amount of equity remaining to sell under an August 2010 agreement with Seaside 88...
BioCentury | Jan 3, 2011
Financial News

NanoViricides completes private placement of convertible preferred stock

...million Shares: 250,000 Price: $10 Placement agent: Midtown Partners Shares outstanding prior: 136.7 million Investor: Seaside 88...
BioCentury | Sep 27, 2010
Financial News

NanoViricides completes private placement of convertible preferred stock

...convertible preferred stock Raised: $2.5 million Shares: 250,000 Price: $10 Placement agent: Midtown Partners Investor: Seaside 88...
Items per page:
1 - 10 of 21
BioCentury | Mar 4, 2013
Financial News

NanoViricides financial update

...to Seaside 88 for $2 million, including accrued dividends of $6,002.45 and a 10% redemption premium. Seaside 88...
BioCentury | Jan 7, 2013
Financial News

NanoViricides completes private placement of convertible preferred stock

...million Shares: 2,500 Price: $1,000 Placement agent: Midtown Partners Shares outstanding prior: 159.4 million Investor: Seaside 88...
BioCentury | Feb 13, 2012
Financial News

NanoViricides completes private placement of convertible preferred stock

...convertible preferred stock Raised: $2.5 million Shares: 250,000 Price: $10 Placement agent: Midtown Partners Investor: Seaside 88...
BioCentury | Nov 7, 2011
Financial News

NanoViricides completes private placement of convertible preferred stock

...million Shares: 250,000 Price: $10 Placement agent: Midtown Partners Shares outstanding prior: 145.8 million Investor: Seaside 88...
BioCentury | Aug 1, 2011
Financial News

NanoViricides completes private placement of convertible preferred stock

...million Shares: 250,000 Price: $10 Placement agent: Midtown Partners Shares outstanding prior: 142.1 million Investor: Seaside 88...
BioCentury | Jul 18, 2011
Financial News

Cytori completes private placement

...placement Raised: $6 million Shares: 1.3 million Price: $4.52 Shares after offering: 53.8 million Investor: Seaside 88...
BioCentury | Apr 25, 2011
Financial News

NanoViricides completes private placement of convertible preferred stock

...convertible preferred stock Raised: $2.5 million Shares: 250,000 Price: $10 Placement agent: Midtown Partners Investor: Seaside 88...
BioCentury | Feb 14, 2011
Finance

Hard to Mann up

...has an undisclosed amount of equity remaining to sell under an August 2010 agreement with Seaside 88...
BioCentury | Jan 3, 2011
Financial News

NanoViricides completes private placement of convertible preferred stock

...million Shares: 250,000 Price: $10 Placement agent: Midtown Partners Shares outstanding prior: 136.7 million Investor: Seaside 88...
BioCentury | Sep 27, 2010
Financial News

NanoViricides completes private placement of convertible preferred stock

...convertible preferred stock Raised: $2.5 million Shares: 250,000 Price: $10 Placement agent: Midtown Partners Investor: Seaside 88...
Items per page:
1 - 10 of 21